Genomic reconstruction of the SARS-CoV-2 epidemic in England | Nature
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
Professor Jason Pole - Centre for Health Services Research - University of Queensland
Executive Leadership - AZ Care Network
Petros George Nikolinakos, MD Managing Partner and Director of Clinical Research - University Cancer & Blood Center
Brown Annual Fund 2019-2020 Donor Book by Brown Annual Fund - Issuu
Coordinated Care Transforms Lives - AZ Care Network
Genentech: Christian Hammer | Senior Principal Scientist, Cancer Immunology & Human Genetics
Open Letter to Vice President Mike Pence RE: US COVID-19 Response | by Dr. Maxine Dexter and Dr. Smitha Chadaga | Medical Professionals for a better COVID-19 Response | Medium
Gothic Fantasy
Pin on admirable artists.
CLA Dean's List | Undergraduate Students | College of Liberal Arts
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates | Science Advances
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK - The Lancet Respiratory Medicine
For Providers Archives - AZ Care Network
Cytokine release syndrome in severe COVID-19 | Science
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms | ACS Omega
Celebration of Outstanding Achievements – Faculty of Applied Health Sciences
Genentech: Brian Yaspan | Senior Principal Scientist, OMNI Human Genetics
Mapping the human genetic architecture of COVID-19 | Nature
Genetic mechanisms of critical illness in COVID-19 | Nature
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters
Axion dark matter: What is it and why now? | Science Advances
Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design | Journal of Medicinal Chemistry
